Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Smart AFO and 5-Azacitidine for Gait in Children With Cerebral Palsy
NCT07434492Phase 2Recruiting
- Sponsor
- Shirley Ryan AbilityLab
- Start
- May 2026
- Primary completion
- Aug 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine in cerebral palsy (CP), sponsored by Shirley Ryan AbilityLab. Started May 2026; status: recruiting.
02
Drugs
azacitidine
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT07434492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07434492.